Literature DB >> 26601733

Misoprostol for induction of labor.

Megan L Stephenson1, Deborah A Wing2.   

Abstract

Labor-induction rates have increased considerably in the United States as well as around the world. With up to half of all induced labors requiring cervical ripening, prostaglandins have been utilized to increase induction success and achieve vaginal delivery. Misoprostol, a synthetic prostaglandin E1 analog has the ability to mimic the changes of spontaneous labor and has been used off label for over 30 years as a labor-induction agent. In the following article, cervical ripening and induction of labor with misoprostol will be discussed. The risks and benefits of misoprostol for ripening and induction and routes of administration will be reviewed, as well as future directions and new developments for its use.
Copyright © 2015. Published by Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26601733     DOI: 10.1053/j.semperi.2015.07.008

Source DB:  PubMed          Journal:  Semin Perinatol        ISSN: 0146-0005            Impact factor:   3.300


  5 in total

1.  A comparison of vaginal versus buccal misoprostol for cervical ripening in women for labor induction at term (the IMPROVE trial): a triple-masked randomized controlled trial.

Authors:  David M Haas; Joanne Daggy; Kathleen M Flannery; Meredith L Dorr; Carrie Bonsack; Surya S Bhamidipalli; Rebecca C Pierson; Anthony Lathrop; Rachel Towns; Nicole Ngo; Annette Head; Sarah Morgan; Sara K Quinney
Journal:  Am J Obstet Gynecol       Date:  2019-05-07       Impact factor: 8.661

2.  Labor Induction with Orally Administrated Misoprostol: A Retrospective Cohort Study.

Authors:  Tove Wallstrom; Hans Jarnbert-Pettersson; David Stenson; Helena Akerud; Elisabeth Darj; Kristina Gemzell-Danielsson; Eva Wiberg-Itzel
Journal:  Biomed Res Int       Date:  2017-09-18       Impact factor: 3.411

Review 3.  Obesity in pregnancy: a novel concept on the roles of adipokines in uterine contractility.

Authors:  Judit Hajagos-Tóth; Eszter Ducza; Reza Samavati; Sandor G Vari; Robert Gaspar
Journal:  Croat Med J       Date:  2017-04-14       Impact factor: 1.351

4.  Labor induction with randomized comparison of cervical, oral and intravaginal misoprostol.

Authors:  Masoumeh Dadashaliha; Somayeh Fallah; Monirsadat Mirzadeh
Journal:  BMC Pregnancy Childbirth       Date:  2021-10-27       Impact factor: 3.007

5.  Misoprostol complications in second-trimester termination of pregnancy among women with a history of more than one cesarean section.

Authors:  Marzieh Jamali; Mahmood Bakhtiyari; Fatemeh Arab; Masoumeh Mirzamoradi
Journal:  Obstet Gynecol Sci       Date:  2020-04-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.